DEXELANCE SPA (DEX.MI) Stock Fundamental Analysis

Europe • Euronext Milan • BIT:DEX • IT0005543480

3.78 EUR
-0.09 (-2.33%)
Last: Feb 2, 2026, 07:00 PM
Fundamental Rating

4

Taking everything into account, DEX scores 4 out of 10 in our fundamental rating. DEX was compared to 33 industry peers in the Household Durables industry. While DEX is still in line with the averages on profitability rating, there are concerns on its financial health. DEX is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • DEX had positive earnings in the past year.
  • In the past year DEX had a positive cash flow from operations.
  • DEX had positive earnings in 4 of the past 5 years.
  • DEX had a positive operating cash flow in each of the past 5 years.
DEX.MI Yearly Net Income VS EBIT VS OCF VS FCFDEX.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 10M 20M 30M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 2.20%, DEX is in line with its industry, outperforming 57.58% of the companies in the same industry.
  • DEX has a Return On Equity of 5.87%. This is in the better half of the industry: DEX outperforms 60.61% of its industry peers.
  • DEX has a Return On Invested Capital of 3.48%. This is comparable to the rest of the industry: DEX outperforms 42.42% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for DEX is in line with the industry average of 9.38%.
  • The last Return On Invested Capital (3.48%) for DEX is well below the 3 year average (7.89%), which needs to be investigated, but indicates that DEX had better years and this may not be a problem.
Industry RankSector Rank
ROA 2.2%
ROE 5.87%
ROIC 3.48%
ROA(3y)2.51%
ROA(5y)3.41%
ROE(3y)6.18%
ROE(5y)10.61%
ROIC(3y)7.89%
ROIC(5y)6.91%
DEX.MI Yearly ROA, ROE, ROICDEX.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 5 -5 10 -10 15

1.3 Margins

  • DEX has a Profit Margin (1.97%) which is comparable to the rest of the industry.
  • DEX's Profit Margin has declined in the last couple of years.
  • Looking at the Operating Margin, with a value of 2.98%, DEX is in line with its industry, outperforming 42.42% of the companies in the same industry.
  • In the last couple of years the Operating Margin of DEX has declined.
  • The Gross Margin of DEX (37.82%) is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of DEX has grown nicely.
Industry RankSector Rank
OM 2.98%
PM (TTM) 1.97%
GM 37.82%
OM growth 3Y-4.54%
OM growth 5YN/A
PM growth 3Y-11.3%
PM growth 5YN/A
GM growth 3Y7.21%
GM growth 5YN/A
DEX.MI Yearly Profit, Operating, Gross MarginsDEX.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 10 20 30 40

More info and screens

3

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), DEX is creating some value.
  • DEX has less shares outstanding than it did 1 year ago.
  • Compared to 1 year ago, DEX has an improved debt to assets ratio.
DEX.MI Yearly Shares OutstandingDEX.MI Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
DEX.MI Yearly Total Debt VS Total AssetsDEX.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

  • DEX has an Altman-Z score of 1.70. This is a bad value and indicates that DEX is not financially healthy and even has some risk of bankruptcy.
  • DEX has a worse Altman-Z score (1.70) than 60.61% of its industry peers.
  • The Debt to FCF ratio of DEX is 23.75, which is on the high side as it means it would take DEX, 23.75 years of fcf income to pay off all of its debts.
  • DEX has a Debt to FCF ratio (23.75) which is comparable to the rest of the industry.
  • DEX has a Debt/Equity ratio of 0.34. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.34, DEX is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 23.75
Altman-Z 1.7
ROIC/WACC0.6
WACC5.84%
DEX.MI Yearly LT Debt VS Equity VS FCFDEX.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 50M 100M 150M

2.3 Liquidity

  • A Current Ratio of 1.06 indicates that DEX should not have too much problems paying its short term obligations.
  • With a Current ratio value of 1.06, DEX is not doing good in the industry: 75.76% of the companies in the same industry are doing better.
  • DEX has a Quick Ratio of 1.06. This is a bad value and indicates that DEX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • DEX's Quick ratio of 0.75 is in line compared to the rest of the industry. DEX outperforms 45.45% of its industry peers.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 0.75
DEX.MI Yearly Current Assets VS Current LiabilitesDEX.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

4

3. Growth

3.1 Past

  • The earnings per share for DEX have decreased strongly by -65.75% in the last year.
  • DEX shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 16.38% yearly.
  • Looking at the last year, DEX shows a quite strong growth in Revenue. The Revenue has grown by 9.70% in the last year.
  • Measured over the past years, DEX shows a very strong growth in Revenue. The Revenue has been growing by 31.04% on average per year.
EPS 1Y (TTM)-65.75%
EPS 3Y16.38%
EPS 5YN/A
EPS Q2Q%-825%
Revenue 1Y (TTM)9.7%
Revenue growth 3Y31.04%
Revenue growth 5YN/A
Sales Q2Q%2.53%

3.2 Future

  • The Earnings Per Share is expected to decrease by -8.46% on average over the next years.
  • DEX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.23% yearly.
EPS Next Y-43.72%
EPS Next 2Y-15.18%
EPS Next 3Y-8.46%
EPS Next 5YN/A
Revenue Next Year4.31%
Revenue Next 2Y5.75%
Revenue Next 3Y5.23%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DEX.MI Yearly Revenue VS EstimatesDEX.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
DEX.MI Yearly EPS VS EstimatesDEX.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

  • DEX is valuated reasonably with a Price/Earnings ratio of 11.45.
  • Based on the Price/Earnings ratio, DEX is valued a bit cheaper than 75.76% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 28.25. DEX is valued rather cheaply when compared to this.
  • A Price/Forward Earnings ratio of 6.14 indicates a rather cheap valuation of DEX.
  • DEX's Price/Forward Earnings ratio is rather cheap when compared to the industry. DEX is cheaper than 90.91% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 27.50. DEX is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 11.45
Fwd PE 6.14
DEX.MI Price Earnings VS Forward Price EarningsDEX.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, DEX is valued cheaply inside the industry as 87.88% of the companies are valued more expensively.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as DEX.
Industry RankSector Rank
P/FCF 28.54
EV/EBITDA 4.13
DEX.MI Per share dataDEX.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • A cheap valuation may be justified as DEX's earnings are expected to decrease with -8.46% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-15.18%
EPS Next 3Y-8.46%

More info and screens

0

5. Dividend

5.1 Amount

  • No dividends for DEX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

DEXELANCE SPA

BIT:DEX (2/2/2026, 7:00:00 PM)

3.78

-0.09 (-2.33%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners13.73%
Inst Owner ChangeN/A
Ins Owners3.17%
Ins Owner ChangeN/A
Market Cap101.80M
Revenue(TTM)481.13M
Net Income(TTM)9.48M
Analysts85.71
Price Target8.91 (135.71%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.73%
PT rev (3m)-14.1%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-14.37%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.13%
Valuation
Industry RankSector Rank
PE 11.45
Fwd PE 6.14
P/S 0.21
P/FCF 28.54
P/OCF 9.68
P/B 0.63
P/tB N/A
EV/EBITDA 4.13
EPS(TTM)0.33
EY8.73%
EPS(NY)0.62
Fwd EY16.28%
FCF(TTM)0.13
FCFY3.5%
OCF(TTM)0.39
OCFY10.33%
SpS17.87
BVpS6
TBVpS-2.2
PEG (NY)N/A
PEG (5Y)N/A
Graham Number6.67
Profitability
Industry RankSector Rank
ROA 2.2%
ROE 5.87%
ROCE 4.78%
ROIC 3.48%
ROICexc 3.89%
ROICexgc 22.15%
OM 2.98%
PM (TTM) 1.97%
GM 37.82%
FCFM 0.74%
ROA(3y)2.51%
ROA(5y)3.41%
ROE(3y)6.18%
ROE(5y)10.61%
ROIC(3y)7.89%
ROIC(5y)6.91%
ROICexc(3y)10.38%
ROICexc(5y)9.17%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)10.86%
ROCE(5y)9.5%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-10.93%
ROICexc growth 5YN/A
OM growth 3Y-4.54%
OM growth 5YN/A
PM growth 3Y-11.3%
PM growth 5YN/A
GM growth 3Y7.21%
GM growth 5YN/A
F-Score7
Asset Turnover1.12
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 23.75
Debt/EBITDA 1.49
Cap/Depr 30.32%
Cap/Sales 1.44%
Interest Coverage 250
Cash Conversion 28.23%
Profit Quality 37.61%
Current Ratio 1.06
Quick Ratio 0.75
Altman-Z 1.7
F-Score7
WACC5.84%
ROIC/WACC0.6
Cap/Depr(3y)32.47%
Cap/Depr(5y)34.25%
Cap/Sales(3y)1.91%
Cap/Sales(5y)2.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-65.75%
EPS 3Y16.38%
EPS 5YN/A
EPS Q2Q%-825%
EPS Next Y-43.72%
EPS Next 2Y-15.18%
EPS Next 3Y-8.46%
EPS Next 5YN/A
Revenue 1Y (TTM)9.7%
Revenue growth 3Y31.04%
Revenue growth 5YN/A
Sales Q2Q%2.53%
Revenue Next Year4.31%
Revenue Next 2Y5.75%
Revenue Next 3Y5.23%
Revenue Next 5YN/A
EBIT growth 1Y-62.21%
EBIT growth 3Y25.09%
EBIT growth 5YN/A
EBIT Next Year1.44%
EBIT Next 3Y9.74%
EBIT Next 5YN/A
FCF growth 1Y-74.95%
FCF growth 3Y8.28%
FCF growth 5YN/A
OCF growth 1Y-42.38%
OCF growth 3Y11.3%
OCF growth 5YN/A

DEXELANCE SPA / DEX.MI FAQ

What is the fundamental rating for DEX stock?

ChartMill assigns a fundamental rating of 4 / 10 to DEX.MI.


What is the valuation status for DEX stock?

ChartMill assigns a valuation rating of 6 / 10 to DEXELANCE SPA (DEX.MI). This can be considered as Fairly Valued.


What is the profitability of DEX stock?

DEXELANCE SPA (DEX.MI) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for DEX stock?

The Price/Earnings (PE) ratio for DEXELANCE SPA (DEX.MI) is 11.45 and the Price/Book (PB) ratio is 0.63.


What is the financial health of DEXELANCE SPA (DEX.MI) stock?

The financial health rating of DEXELANCE SPA (DEX.MI) is 3 / 10.